AVROBIO, Inc. (AVRO)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 1.2500 |
| 開市 | 1.2600 |
| 買盤 | 1.2100 x 200 |
| 賣出價 | 1.2400 x 600 |
| 今日波幅 | 1.2200 - 1.2600 |
| 52 週波幅 | 0.5700 - 1.7000 |
| 成交量 | |
| 平均成交量 | 201,665 |
| 市值 | 55.212M |
| Beta 值 (5 年，每月) | 1.24 |
| 市盈率 (最近 12 個月) | 4.56 |
| 每股盈利 (最近 12 個月) | 0.2700 |
| 業績公佈日 | 2024年8月08日 - 2024年8月12日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 2.00 |
BenzingaAvrobio Touts Positive Data Gene Therapy Trial For Cystinosis, Showing Treatment Durability Of Up To 36 Months
Avrobio Inc (NASDAQ: AVRO) announced follow-up data demonstrating a durable treatment effect across key measures out to 36 months from a Phase 1/2 trial of an investigational gene therapy for cystinosis, dubbed AVR-RD-04. Cystinosis is characterized by the accumulation of the amino acid cystine (a building block of proteins) within cells due to deficient protein cystinosin. Excess cystine damages cells and often forms crystals that can build up and cause problems in many organs and tissues. The
